Side Effect Profiles of Brand Name Versus Generic Oral Contraceptives
NCT00775190 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2017-04-17
Summary
This is a randomized control trial of Ortho tricyclen versus Trinessa (generic equivalent) to determine if they have similar effects. Women will be randomized to receive either Ortho tricyclen or Trinessa oral contraceptives and will be asked to keep a daily dairy of any symptoms or bleeding experienced. Once a month, participants will be asked to complete a survey.
The objective is to compare generic oral contraceptives (OCPs) and brand name OCPs with respect to side effect profiles including bleeding patterns, mood changes, nausea and vomiting, frequency of menstrual cramps, breast tenderness, elevation in blood pressure, stroke, blood clots and patient compliance.
Conditions
- Contraception
Interventions
- DRUG
-
ortho tricyclen
brand name oral contraceptive
- DRUG
-
Trinessa
generic oral contraceptive
Sponsors & Collaborators
-
William Beaumont Hospitals
lead OTHER
Principal Investigators
-
Frances Bechek, MD · William Beaumont Hospitals
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 35 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-10-31
- Primary Completion
- 2013-10-31
- Completion
- 2013-11-30
Countries
- United States
Study Locations
More Related Trials
-
An Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen to Norelgestromin/Ethinyl Estradiol Given in a Traditional Regimen
NCT00320580 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating Levonorgestrel and Ethinyl Estradiol in Oral Contraception
NCT00248963 ·Status: COMPLETED ·Phase: PHASE3
-
Drug Interaction - Oral Contraceptive
NCT00399685 ·Status: COMPLETED ·Phase: PHASE1
-
US Cycle Control and Blood Pressure Study
NCT00920985 ·Status: COMPLETED ·Phase: PHASE3
-
Determine the Effects of C-administration of AZD7325 and an Oral Contraceptive in Healthy Female Subjects
NCT00901290 ·Status: SUSPENDED ·Phase: PHASE1
-
A Study to Determine the Effects of PF-04965842 on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female Subjects
NCT03662516 ·Status: COMPLETED ·Phase: PHASE1
-
A Multicenter Study to Evaluate the Safety of Seasonique, an Oral Contraceptive.
NCT00196352 ·Status: COMPLETED ·Phase: PHASE3
-
Oral Versus Patch Hormonal Contraceptive Effects on Metabolism, Clotting, Inflammatory Factors and Vascular Reactivity
NCT00439972 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Evacetrapib in Healthy Female Participants
NCT01746732 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Effects of CC-99677 on the Pharmacokinetics of an Oral Contraceptive in Healthy Female Participants
NCT04718636 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparison of Continuation Rates for Three Hormonal Contraceptive Methods
NCT00253019 ·Status: COMPLETED
-
Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception
NCT00245921 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Safety and Efficacy of an Oral Contraceptive
NCT00391807 ·Status: COMPLETED ·Phase: PHASE3
-
Assessing the Effect of Multiple Doses of Zibotentan on the Pharmacokinetics of Single Doses of Combined Oral Contraceptives in Healthy Female Participants of Non-childbearing Potential.
NCT05505162 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult Women
NCT01953809 ·Status: WITHDRAWN ·Phase: PHASE1
-
Specific Supplementation in Counteracting the Adverse Effects of Oral Contraceptives
NCT07071389 ·Status: WITHDRAWN ·Phase: NA
-
A Drug-drug Interaction Trial in Healthy Female Participants to Investigate the Effect of Aprocitentan on Combined Hormonal Contraceptives
NCT06799884 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LY2216684 in Healthy Females
NCT01373931 ·Status: COMPLETED ·Phase: PHASE1
-
Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use
NCT04112095 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives
NCT01291004 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception
NCT02021097 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparative Trial in Hormone Withdrawal Associated Symptoms
NCT01076582 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Healthy Participants to Evaluate the Effects of Multiple Doses of JNJ-55308942 on Cytochrome P450 Substrate Activity and on the Pharmacokinetics of Levonorgestrel/Ethinyl Estradiol
NCT03547024 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Effects of BMS-986278 on Drospirenone and Ethinyl Estradiol Drug Levels in Healthy Female Participants
NCT05985590 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Lanabecestat in Healthy Female Participants Taking Oral Contraceptive
NCT03506399 ·Status: WITHDRAWN ·Phase: PHASE1